“…Despite its low intrinsic pathogenicity, it can cause serious infections in humans, especially immunocompromised hosts [8, 11, 12]. A. xylosoxidans has been reported in patients with cancer, neutropenia, bone marrow or liver transplant, diabetes mellitus, renal failure, cystic fibrosis, HIV infection, IgM deficiency, neonates, and healthy individuals [2–4, 5–8, 10, 11, 13, 15–17]. The clinical manifestation of infection caused by A. xylosoxidans is variable and includes primary bacteremia, pneumonia, meningitis, endocarditis, cholecystitis, peritonitis, pyelonephritis, osteomyelitis, lymphadenitis and keratitis [3–6, 8, 14, and 18].…”